NASHVILLE, TN--(Marketwire - January 15, 2009) -
OralDNA Labs, Inc. (www.OralDNA.com
specialty diagnostics company focused on bringing advanced laboratory
testing to the dental community, today announced it has entered into an
agreement to be the JP Institute's exclusive partner for diagnostic testing
Under the terms of this agreement, OralDNA and the JP Institute will
conduct joint programs together throughout the United States in 2009,
beginning with a program in Nashville, Tennessee on February 6-7, 2009.
"We are pleased to work with OralDNA Labs in communicating the importance
of diagnostic testing in dentistry," said Jan Lazarus, co-founder of the JP
Institute. "For the 30 past years, our JP Institute team has recognized the
clinical impact of under-diagnosis of periodontal infections. Our team is
extremely excited to finally have clinical lab tests that will improve the
accuracy of diagnosis for these serious infectious diseases. This will
allow Dentists, Hygienists and Periodontists to diagnose and treat these
infections with the importance they deserve. We believe patient care can
improve dramatically by using laboratory tests to identify the specific
cause of infection and to predict the patients that often require more
"OralDNA is pleased to join with a high quality partner like the JP
Institute," said Dr. Tom Nabors, chairman and Chief Dental Officer of
OralDNA Labs. "We are excited that they see the value in diagnostic
testing. Together we can continue to provide the right clinical training
and follow-up for proper implementation. Jan and her team of trainers can
help dental offices implement testing and integrate it into the overall
office protocol for patient care."
About JP Institute (www.jpconsultants.com):
The JP Institute was founded in 1979 and is committed to developing and
supporting clinical patient excellence and dental practice success. Through
initiatives such as in-office training and consulting, Mastership
Certification programs and hands-on training workshops, their curriculum
supports both periodontal and restorative case acceptance. The JP Institute
has been a leading force in helping dental practices achieve excellence by
utilizing evidence-based therapies and integrating new products and
technologies into comprehensive care.
For more information about The JP Institute please call 800-946-4944.
About OralDNA Labs, Inc. (www.OralDNA.com):
OralDNA Labs, Inc. is a specialty diagnostics company created to advance
clinical testing in the dental community. Our goal is to help the dental
profession achieve better clinical outcomes by providing reliable,
definitive and cost effective clinical tests that drive the detection and
prognosis of disease at an earlier, more treatable stage, with an initial
focus on periodontal disease.
Periodontal disease is a bacterial infection that causes an inflammatory
response. The disease is present in an estimated three quarters of the
adult population in the United States, with 30-35% of this population
having a genetic trait which predisposes these individuals to more serious
forms of the disease. If patients are not properly diagnosed and treated
at early stages, periodontal disease can lead to bone loss, tooth loss and
implant failure. Research now suggests an increased risk to a number of
systemic diseases when chronic periodontal infections are left untreated.
OralDNA offers two DNA-PCR tests for periodontal disease diagnosis and
genetic susceptibility. MyPerioPath(SM) detects the presence and quantity
of specific bacteria associated with periodontal disease. MyPerioID(SM)
PST®, licensed through a marketing, sales and distribution agreement with
Interleukin Genetics, provides a means of assessing an individual's genetic
risk for periodontal disease.
The company is also developing an oral HPV test for use in assessing risks
associated with oral cancer. Thereafter, OralDNA intends to develop a
broader menu of clinical laboratory tests for use in oral medicine.